Peripherally inserted central catheters (PICC) are essential for delivering lifesaving treatments to children; however they also introduce significant risk. PICC lines can trigger the body’s thrombotic response, initiating clots on the catheter surface, the first step in a series of events that ultimately leads to clogging of the PICC and infection in the patient. The Bio-Inert PICC utilizes an advanced, FDA approved biomaterial that is bioinert and eliminates fouling and lowers potential for venous death.
- Client Jim Biggins, Access Vascular Inc.
- Date January 3, 2017
- Tags Pre-Seed
- URL View Project